Skip to main content
. 2021 Sep 9;9(4):100581. doi: 10.1016/j.hjdsi.2021.100581

Fig. 1.

Fig. 1

Timeline of events. The COVID-19 Rapid Practice Improvement Deployment (RaPID) study of tocilizumab successfully extracted, analyzed, and disseminated its findings to key stakeholders in less than one week.